Report Presented at the September 14, 2004 Press Conference Sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. Antidepressant-Induced Suicidality and Violence: More About Deception than Science Observations Made at the FDA Hearings Press Conference, September 14, 2004 By Peter R. […]
Read More
by Peter R. Breggin, M.D. On March 22 the FDA issued an extraordinary “Public Health Advisory” that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The […]
Read More
Originally posted on the FDA site (03/22/04) @ http://www.fda.gov/bbs/topics/ANSWERS/2004/ans01283.html The Food and Drug Administration today issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at the beginning of […]
Read More
The FDA Continues to Affirm Antidepressant Risks First Identified in my 1991 Book Toxic Psychiatry By Peter R. Breggin, M.D. Ithaca, New York www.breggin.com In 2004 the FDA issued a black box warning about the increased risk of suicidality in children taking the newer antidepressants, including the SSRIs (Prozac, […]
Read More
Read More
of Peter Breggin, M.D., 1954 to the Present Many of Dr. Breggin’s accomplishments as a reformer are documented in detail in The Conscience of Psychiatry: The Reform Work of Peter R. Breggin, M.D. (2009). This biographical tribute to Dr. Breggin’s work draws on more than half-a-century of media and more […]
Read More
Eli LillyWithheld Prozac Documents–website version.pdf
Read More
Dr. Breggin’s educational campaigns and his scientific research contributed have put pressure on the FDA to change the contents of numerous FDA-approved labels for psychiatric drugs, including the neuroleptic (antipsychotic) drugs and the newer antidepressants. Dr. Breggin’s articles about the FDA, especially the implications of recent label changes, can be […]
Read More
Dr. Peter Breggin’s new concept of medication spellbinding provides insights into why so many people take psychiatric drugs when the drugs are doing more harm than good. Psychiatric drugs, and all other drugs that affect the mind, spellbind the individual by masking their adverse mental effects from the individual […]
Read More
THREE-JUDGE OPINION ULTIMATELY ENDS PSYCHOSURGERY IN STATE HOSPITALS, VA AND NIH DR. BREGGIN’S TESTIMONY SETS STAGE TO INVOKE NUREMBERG CODE The following is excerpted and slightly revised from a longer article by Dr. Breggin on the history of his reform work in stopping the return of lobotomy and psychosurgery in […]
Read More